GSTO1C/GSTO2G Haplotype is Associated with Risk of Transitional Cell Carcinoma of Urinary Bladder

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2015 Feb 27

PMID 25716313

Citations 6

Authors

Tatjana Djukic

Tatjana Simic

Tanja Radic

Marija Matic

Marija Pljesa-Ercegovac

Sonja Suvakov

Vesna Coric

Tatjana Pekmezovic

Ivana Novakovic

Dejan Dragicevic

Ana Savic-Radojevic

Affiliations

Soon will be listed here.

Abstract

Purpose: To clarify the role of genetic polymorphisms of GSTO1 (rs4925) and GSTO2 (rs156697) in individual susceptibility to urinary bladder cancer.

Methods: Case-control study consisting of 187 patients with histologically confirmed transitional cell carcinoma (TCC) of urinary bladder and 140 age- and gender-matched cancer-free controls was carried out. Genotyping of GSTO1 and GSTO2 was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: We found that carriers of mutant GSTO2*G/G genotype were at increased risk of the development of TCC (OR 2.6, 95% CI 1.2-5.8, p = 0.041), while GSTO1 rs4925 polymorphism was not significantly associated with TCC risk (p = 0.450). According to smoking status, smokers with GSTO2*G/G genotype had significantly higher risk of TCC of urinary bladder (OR 4.3, 95% CI 1.6-11.2, p = 0.003) compared to wild-type carriers with no smoking history. We further analyzed the effects of GSTO1/GSTO2 haplotypes on TCC risk, based on the linkage disequilibrium found for GSTO1 (rs4925) and GSTO2 (rs156697) (D' = 0.309, p = 0.001). The study subjects with GSTO1*C/GSTO2*G (GSTO1 wild-type/GSTO2 mutant) haplotype were at the highest risk of the development of transitional cell carcinoma of urinary bladder (OR 2.8, 95% CI 1.5-5.2, p = 0.002).

Conclusions: Our results indicate that GSTO1*C/GSTO2*G haplotype is associated with increased risk of TCC. The modifying effect of GSTO2*G/G genotype on individual susceptibility to TCC is more pronounced, when associated with smoking.

Citing Articles

The Role of Glutathione Transferase Omega-Class Variant Alleles in Individual Susceptibility to Ovarian Cancer.

Simic P, Coric V, Pljesa I, Savic-Radojevic A, Zecevic N, Kocic J Int J Mol Sci. 2024; 25(9).

PMID: 38732205 PMC: 11084357. DOI: 10.3390/ijms25094986.

Genetic Polymorphisms Involved in Bladder Cancer: A Global Review.

Kourie H, Zouein J, Succar B, Mardirossian A, Ahmadieh N, Chouery E Oncol Rev. 2023; 17:10603.

PMID: 38025894 PMC: 10657888. DOI: 10.3389/or.2023.10603.

The Polymorphisms in Genes ( rs4925, rs156697, and rs2297235) Affect the Risk for Testicular Germ Cell Tumor Development: A Pilot Study.

Petrovic M, Simic T, Djukic T, Radic T, Savic-Radojevic A, Zekovic M Life (Basel). 2023; 13(6).

PMID: 37374052 PMC: 10301167. DOI: 10.3390/life13061269.

Polymorphisms in Genes Encoding Glutathione Transferase Pi and Glutathione Transferase Omega Influence Prostate Cancer Risk and Prognosis.

Santric V, Dragicevic D, Matic M, Djokic M, Pljesa-Ercegovac M, Radic T Front Mol Biosci. 2021; 8:620690.

PMID: 33937322 PMC: 8079946. DOI: 10.3389/fmolb.2021.620690.

Association between arsenic metabolism gene polymorphisms and arsenic-induced skin lesions in individuals exposed to high-dose inorganic arsenic in northwest China.

Luo L, Li Y, Gao Y, Zhao L, Feng H, Wei W Sci Rep. 2018; 8(1):413.

PMID: 29323258 PMC: 5765042. DOI: 10.1038/s41598-017-18925-3.

References

Whitbread A, Masoumi A, Tetlow N, Schmuck E, Coggan M, Board P . Characterization of the omega class of glutathione transferases. Methods Enzymol. 2006; 401:78-99. DOI: 10.1016/S0076-6879(05)01005-0. View

Piaggi S, Raggi C, Corti A, Pitzalis E, Mascherpa M, Saviozzi M . Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity. Carcinogenesis. 2010; 31(5):804-11. DOI: 10.1093/carcin/bgq031. View

Yanbaeva D, Wouters E, Dentener M, Spruit M, Reynaert N . Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radic Res. 2009; 43(8):738-43. DOI: 10.1080/10715760903038440. View

Sanguansin S, Petmitr S, O-Charoenrat P, Pongstaporn W . Association of glutathione S-transferase omega gene polymorphisms with progression of head and neck cancer. Mol Biol Rep. 2012; 39(12):10915-20. DOI: 10.1007/s11033-012-1991-3. View

Kang H, Song P, Ha Y, Kim W, Kim Y, Yun S . Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients. Eur J Cancer. 2013; 49(14):3010-9. DOI: 10.1016/j.ejca.2013.05.019. View

Marahatta S, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S . Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett. 2005; 236(2):276-81. DOI: 10.1016/j.canlet.2005.05.020. View

Piacentini S, Monaci P, Polimanti R, Manfellotto D, Fuciarelli M . GSTO2*N142D gene polymorphism associated with hypothyroidism in Italian patients. Mol Biol Rep. 2012; 40(2):1967-71. DOI: 10.1007/s11033-012-2253-0. View

Tian W, Wang Y, Xu Y, Guo X, Wang B, Sun L . The hypoxia-inducible factor renders cancer cells more sensitive to vitamin C-induced toxicity. J Biol Chem. 2013; 289(6):3339-51. PMC: 3916538. DOI: 10.1074/jbc.M113.538157. View

Hayes J, Flanagan J, Jowsey I . Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005; 45:51-88. DOI: 10.1146/annurev.pharmtox.45.120403.095857. View

10.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B . GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Urol Oncol. 2013; 31(7):1184-92. DOI: 10.1016/j.urolonc.2011.08.005. View

11.

Masoudi M, Saadat I, Omidvari S, Saadat M . Association between N142D genetic polymorphism of GSTO2 and susceptibility to colorectal cancer. Mol Biol Rep. 2010; 38(7):4309-13. DOI: 10.1007/s11033-010-0555-7. View

12.

Zhou H, Brock J, Liu D, Board P, Oakley A . Structural insights into the dehydroascorbate reductase activity of human omega-class glutathione transferases. J Mol Biol. 2012; 420(3):190-203. DOI: 10.1016/j.jmb.2012.04.014. View

13.

Chung C, Pu Y, Su C, Huang C, Hsueh Y . Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Sci Total Environ. 2010; 409(3):465-70. DOI: 10.1016/j.scitotenv.2010.10.053. View

14.

Wang Y, Yeh S, Shen K, Shen C, Juang G, Hsu L . A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Toxicol Appl Pharmacol. 2009; 241(1):111-8. DOI: 10.1016/j.taap.2009.08.008. View

15.

Menon D, Board P . A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle. J Biol Chem. 2013; 288(36):25769-25779. PMC: 3764784. DOI: 10.1074/jbc.M113.487785. View

16.

Traber M, Stevens J . Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med. 2011; 51(5):1000-13. PMC: 3156342. DOI: 10.1016/j.freeradbiomed.2011.05.017. View

17.

Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, Opacic M, Dragicevic D, Kravic T . Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol. 2007; 52(2):470-7. DOI: 10.1016/j.eururo.2007.01.046. View

18.

Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, Mimic-Oka J, Matic M, Sasic T . Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol Oncol. 2009; 29(1):70-7. DOI: 10.1016/j.urolonc.2008.10.019. View

19.

Li Y, Oliveira S, Xu P, Martin E, Stenger J, Scherzer C . Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003; 12(24):3259-67. DOI: 10.1093/hmg/ddg357. View

20.

Engel L, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus P, Lan Q . Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol. 2002; 156(2):95-109. DOI: 10.1093/aje/kwf018. View

GSTO1*C/GSTO2*G Haplotype is Associated with Risk of Transitional Cell Carcinoma of Urinary Bladder

GSTO1C/GSTO2G Haplotype is Associated with Risk of Transitional Cell Carcinoma of Urinary Bladder